AdventHealth Physician Team Performs Central Florida’s First Immediate Breast Neurotization After Nipple-sparing Mastectomy

Published date: |
Estimated read time: |
Authored by:
  • AdventHealth
Topics:
Clinical Excellence Innovation
Breast Neurotization Procedure Photo

Plastic and Reconstructive Microsurgeon Sabrina Pavri, MD, and Breast Surgeon Devina McCray, MD, recently began offering immediate neurotization after breast reconstruction, a new surgical technique designed to restore breast sensation after nipple-sparing mastectomy. They performed Central Florida’s first such procedure at AdventHealth Orlando.

Loss of Sensation After Mastectomy

When breast tissue is removed during mastectomy, the nerves that supply feeling to the breast and nipple are severed, disrupting nerve signals. This can leave the breasts with a total or near total loss of sensation. In fact, nearly 80% of women experience pain, numbness or both after breast cancer surgery, and for many, this loss of sensation becomes a barrier to physical, psychological and emotional recovery.

“Losing one or both breasts can be overwhelming and is a primary reason many women choose reconstructive surgery,” shares Dr. McCray. “Unfortunately, women can also experience partial to complete numbness in their chest after surgery, negatively impacting their quality of life.”

How Breast Neurotization Works

Performed at the same time as breast reconstruction, breast neurotization involves using an allograft nerve to reconnect the lateral intercostal nerve to the underside of the nipple and areolar complex. The allograft acts a scaffold and a guide to allow the nerve to regenerate without tension in the reconstructed breast. As the nerve fibers grow, they have the potential to gradually restore sensation to the breast.

“Breast neurotization is changing the paradigm of breast reconstruction,” explains Dr. Pavri. “Now we can provide patients the opportunity to both look and feel more like themselves again.”

Dr. McCray concurs, “We are excited about this new approach to help women still feel whole after their journey with breast cancer.”

Refer a Patient

Recent News

News

AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease

While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...

Read Article
News

AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)

Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...

Read Article
News

AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease

Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...

Read Article
News

New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy

Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...

Read Article
News

AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease

Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...

Read Article